Ameli Ellen Claesdotter Tropé
Department director Cervicalscreen Norway
Contact
Mob: +47 229 28 723
Send email {model.translations.sendEmailTo} Ameli.Ellen.Claesdotter.Trope@fhi.no
Department
Projects and publications
- Ingrid Baasland, Tone Bjørge, Birgit Øvstebø Engesæter, Ameli Ellen Claesdotter Tropé, Signe Opdahl, (2025). Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment. PLOS ONE doi: 10.1371/journal.pone.0320739
- Tone Bjørge, Nathalie Charlotte Støer, Sara Kristine Kildal Hverven, Mari Kiens Nygård, Ameli Ellen Claesdotter Tropé, Birgit Øvstebø Engesæter, (2025). Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study. International Journal of Cancer doi: 10.1002/ijc.35359
- Ane-Kersti Skaarup Knudsen, Tina Hovgaard Randrup, Ulrik Schiøler Kesmodel, Berit Booth, Line Gustafson, Ameli Ellen Claesdotter Tropé, Björn Strander, Pekka Nieminen, Anne Hammer, (2024). Assessment of a colposcopic scoring system (Swedescore) to reduce the number of cervical biopsies: a protocol for a clinical multicentre non-randomised intervention study in Denmark. BMJ Open doi: 10.1136/bmjopen-2024-085382
- Veli-Matti Partanen, Joakim Dillner, Ameli Ellen Claesdotter Tropé, Ágúst Ingi Agústsson, Stefan Lönnberg, Sirpa Heinävaara, Ahti Anttila, (2024). Divergent effects of switching from cytology to HPV-based screening in the Nordic countries. European Journal of Public Health s. 354-360. doi: 10.1093/eurpub/ckad225
- Allison Portnoy, Kine Pedersen, Stephen Sy, Ameli Ellen Claesdotter Tropé, Birgit Øvstebø Engesæter, Jane J. Kim, Emily Annika Burger, (2023). Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis. International Journal of Cancer doi: 10.1002/ijc.34804
- Priyanthi Borgen Gjerde, Mette Christophersen Tollånes, Ameli Ellen Claesdotter Tropé, Maj Liv Eide, Marianne Natvik, Hanne Eknes Puntervoll, (2023). Livmorhalsprøvetaking i primærhelsetjenesten. Tidsskrift for Den norske legeforening (Tidsskriftet) doi: 10.4045/tidsskr.23.0066
- Madleen Orumaa, Suzanne Campbell, Nathalie Charlotte Støer, Philip E. Castle, Sagar Sen, Ameli Trope, Adebola Adedimeji, Mari Nygård, (2022). Impact of the mobile game FightHPV on cervical cancer screening attendance: Retrospective cohort study. JMIR Serious Games doi: 10.2196/36197
- Tone Bjørge, Birgit Øvstebø Engesæter, Gry Baadstrand Skare, Ameli Trope, (2022). CervicalScreen Norway – A screening programme in transition. Norsk Epidemiologi s. 55-60. doi: 10.5324/nje.v30i1-2.4978
- Mari Nygård, Birgit Øvstebø Engesæter, Philip E. Castle, Jannicke Berland, Maj Liv Eide, Ole-Erik Iversen, Christine M Jonassen, Irene Kraus Christiansen, Olav Karsten Vintermyr, Ameli Trope, (2022). Randomized implementation of a primary human papillomavirus testing-based cervical cancer screening protocol for women 34 to 69 years in Norway. Cancer Epidemiology, Biomarkers and Prevention s. 1812-1822. doi: 10.1158/1055-9965.EPI-22-0340
- Gunvor Aasbø, Ameli Trope, Mari Nygård, Irene Kraus Christiansen, Ingrid Baasland, Grete Alræk Iversen, Ane Cecilie Dæhli Munk, Marit Halonen Christiansen, Gro Kummeneje Presthus, Karina Undem, Tone Bjørge, Philip E. Castle, Bo Lars Thorvald Terning Hansen, (2022). HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial. British Journal of Cancer s. 1816-1826. doi: 10.1038/s41416-022-01954-9
- Kine Pedersen, Allison Portnoy, Stephen Sy, Bo T. Hansen, Ameli Trope, Jane J. Kim, Emily Annika Burger, (2021). Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women. International Journal of Cancer doi: 10.1002/ijc.33850
- Veli-Matti Partanen, Joakim Dillner, Ameli Trope, Ágúst Ingi Ágústsson, Maiju Pankakoski, Sirpa Heinävaara, Tytti Sarkeala, Jiangrong Wang, Gry Baadstrand Skare, Ahti Anttila, Stefan Lönnberg, (2021). Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries. Journal of Medical Screening s. 1-8. doi: 10.1177/0969141321992404
- Thea Beate Brevik, Ameli Trope, Petter Laake, Stål Bjørkly, (2021). Does women’s screening history have any impact on mammography screening attendance after tailored education? : A systematic review and meta-analysis . Medical Care s. 893-900. doi: 10.1097/MLR.0000000000001576
- Forsell Sabrina, Kalliala Ilkka, Halttunen-Nieminen Mervi, Redman Charles, Leeson Simon, Ameli Trope, Moss Esther, Kyrgiou Maria, Pyörälä Eeva, Nieminen Pekka, (2020). Fostering Prevention of Cervical Cancer by a Correct Diagnosis of Precursors: A Structured Case-Based Colposcopy Course in Finland, Norway and UK. Cancers s. 1-12. doi: 10.3390/cancers12113201
- Dana Kristjansson, Birgit Øvstebø Engesæter, Gry Baadstrand Skare, Philip E. Castle, Tone Bjørge, Ameli Trope, Mari Nygård, (2020). Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. British Journal of Cancer s. 1715-1723. doi: 10.1038/s41416-020-0790-1
- Veli-Matti Partanen, Sirpa Heinävaara, Marianne Waldstrøm, Klara Miriam Elfström, Ameli Trope, Ágúst Ingi Ágústsson, Svanhildur Thorsteinsdottir, Gry Baadstrand Skare, Stefan Lönnberg, (2020). Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes. Acta Oncologica s. 1308-1315. doi: 10.1080/0284186X.2020.1821089
- Veli-Matti Partanen, Ahti Anttila, Sirpa Heinävaara, Maiju Pankakoski, Tytti Sarkeala, Zurab Bzhalava, Klara Miriam Elfström, Ameli Trope, Gry Baadstrand Skare, Svanhildur Thorsteinsdottir, Agust Ingi Agustsson, Piret Veerus, Liisa Koreinik, Joakim Dillner, Stefan Lönnberg, (2019). NordScreen?an interactive tool for presenting cervical cancer screening indicators in the Nordic countries. Acta Oncologica s. 1199-1204. doi: 10.1080/0284186X.2019.1615637
- Gunvor Aasbø, Kari Nyheim Solbrække, Jo Waller, Ameli Trope, Mari Nygård, Bo Terning Hansen, (2019). Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study. BMJ Open doi: 10.1136/bmjopen-2019-029505
- Tomas Ruiz-Lopez, Sagar Sen, Elisabeth Stenberg Jakobsen, Ameli Trope, Philip E. Castle, Bo Terning Hansen, Mari Nygård, (2019). FightHPV: Design and Evaluation of a Mobile Game to Raise Awareness About Human Papillomavirus and Nudge People to Take Action Against Cervical Cancer. Journal of Medical Internet Research (JMIR) s. 1-14. doi: 10.2196/games.8540
- Trude Andreassen, Bo Terning Hansen, Birgit Øvstebø Engesæter, Dana Hashim, Nathalie Charlotte Støer, Ameli Trope, Kåre Moen, Giske Ursin, Elisabete Weiderpass, (2019). Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing. International Journal of Cancer s. 29-39. doi: 10.1002/ijc.32067
- Maarit Leinonen, Kristina Schee, Christine M Jonassen, Kathrine Lie, Camilla Bø Furlund, Anbjørg Rangberg, Ingegerd Eggen Furre, Marzena J. Johansson, Ameli Trope, Katrine Dønvold Sjøborg, Philip E. Castle, Mari Nygård, (2018). Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions. Journal of Clinical Virology s. 22-30. doi: 10.1016/j.jcv.2017.12.008
- Agnes Kathrine Lie, Ameli Trope, Gry Baadstrand Skare, Tone Bjørge, Christine M Jonassen, Kjersti Brusegard, Stefan Lönnberg, (2017). HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia. Gynecologic Oncology s. 111-117. doi: 10.1016/j.ygyno.2017.10.031
- Maarit Leinonen, Suzanne Campbell, Giske Ursin, Ameli Trope, Mari Nygård, (2017). Barriers to cervical cancer screening faced by immigrants: A registry-based study of 1.4 million women in Norway. European Journal of Public Health s. 873-879. doi: 10.1093/eurpub/ckx093
- Stefan Lönnberg, Trude Andreassen, Birgit Øvstebø Engesæter, Rune Lilleng, Cecilia Kleven, Annelie Skare, Karin Johansson, Christina Stangeland Fredheim, Ameli Trope, (2016). Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention. BMJ Open s. 1-7. doi: 10.1136/bmjopen-2016-013728
- Tone Bjørge, Gry Baadstrand Skare, Line Bjørge, Ameli Trope, Stefan Lönnberg, (2016). Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. Obstetrics and Gynecology s. 1265-1273. doi: 10.1097/AOG.0000000000001777
- Ameli Ellen Claesdotter Tropé, Katrine Dønvold Sjøborg, Mari Nygård, Kjetil Røysland, Suzanne Campbell, Glenny Cecilie Alfsen, Christine M Jonassen, (2012). Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High-Grade Cervical Neoplasia between Screening Rounds. Journal of Clinical Microbiology s. 1927-1935. doi: 10.1128/JCM.00265-12
- Ameli Ellen Claesdotter Tropé, Christine M Jonassen, Katrine Dønvold Sjøborg, Mari Nygård, Fredrik Andreas Dahl, Glenny Cecilie Alfsen, Kathrine Lie, (2011). Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia. Gynecologic Oncology s. 257-262. doi: 10.1016/j.ygyno.2011.07.032
- Katrine Dønvold Sjøborg, Ameli Ellen Claesdotter Tropé, Agnes Kathrine Lie, Christine M Jonassen, Martin Steinbakk, Mona Lindsethmo Hansen, Morten Jacobsen, K Cuschieri, Anne Eskild, (2010). HPV genotype distribution according to severity of cervical neoplasia. Gynecologic Oncology s. 29-34. doi: 10.1016/j.ygyno.2010.03.007
- Ameli Ellen Claesdotter Trope, Katrine Dønvold Sjøborg, Anne Eskild, Kate Cuschieri, Tormod Eriksen, Steinar Thoresen, Martin Steinbakk, Vigdis Laurak, Christine M Jonassen, Unni Westerhagen, Morten B Jacobsen, Agnes Kathrine Lie, (2009). Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. Journal of Clinical Microbiology s. 2458-2464. doi: 10.1128/JCM.01863-08
- linn Groeneveld, Birgit Engesæter, Gunvor Aasbø, Mona Hansen, Irene Kraus Christiansen, Jannicke Berland, Christine M Jonassen, Emily Annika Burger, Kine Pedersen, Bo Terning Hansen, Ida McFadzean, Kristin Hoel Brenden, Bjørn Eklund, Ameli Trope, (2021). Prosjektforslag hjemmetest: Implementering av hjemmeprøvetaking i Livmorhalsprogrammet.
- Eddy Grønset, Ingrid Baasland, Ameli Ellen Claesdotter Tropé, Sveinung Sørbye, (2023). Spørsmål om HPV, HPV-vaksine eller livmorhalskreft.
- Ingrid Baasland, Signe Opdahl, Tone Bjørge, Ameli Trope, Birgit Øvstebø Engesæter, Gry Baadstrand Skare, (2021). Long-term risk of progression following CIN1.
- Giske Ursin, Solveig Hofvind, Ameli Trope, (2017). Dynamiske screeningsprogrammer. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 974-975. doi: 10.4045/tidsskr.17.0576
- Ameli Trope, Mari Nygård, Birgit Øvstebø Engesæter, Trude Andreassen, Stefan Lönnberg, Giske Ursin, (2017). Trygg implementering av HPV-testing i Livmorhalsprogrammet :. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 1274-1275. doi: 10.4045/tidsskr.17.0306
- Katrine Dønvold Sjøborg, Agnes Kathrine Lie, Ameli Ellen Claesdotter Tropé, Christine M Jonassen, Kate Cuschieri, Anne Eskild, (2010). HPV Genotype Distribution According to Severity of Cervical Neoplasia. Modern Pathology s. 264A-264A.
- Katrine Dønvold Sjøborg, Agnes Kathrine Lie, Ameli Ellen Claesdotter Trope, CM Jonassen, C Cuschieri, Anne Eskild, (2010). HPV genotype distribution according to severity of cervical neoplasia. APMIS - Journal of Pathologiy, Microbiology and Immunology s. 252-252.
- Katrine Dønvold Sjøborg, AK Lie, Ameli Ellen Claesdotter Tropé, CM Jonassen, C Cuschieri, Anne Eskild, (2010). HPV Genotype Distribution According to Severity of Cervical Neoplasia. Laboratory Investigation s. 264A-264A.